BioMarin Pharmaceutical Inc. BMRN
NASDAQ · United States · Health Technology
$59.64-0.36 (-0.60%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | 1.20 | 0.95 | +26.7% | $989.71M | +6.2% | +6.5%$59.91→$63.81 |
| Q1 2026 | 2026-05-04 | 0.76 | 0.91 | -16.5% | — | — | -1.5%$54.06→$53.24 |
| Q4 2025 | 2026-02-23 | 0.46 | 0.56 | -17.9% | — | — | -2.3%$64.08→$62.62 |
| Q3 2025 | 2025-10-27 | 0.12 | 0.34 | -64.7% | — | — | -1.8%$54.48→$53.49 |
| Q2 2025 | 2025-08-04 | 1.44 | 1.03 | +39.8% | — | — | — |
| Q1 2025 | 2025-05-01 | 1.13 | 0.95 | +18.9% | — | — | — |
| Q4 2024 | 2025-02-19 | 0.92 | 0.74 | +24.3% | — | — | — |
| Q3 2024 | 2024-10-29 | 0.91 | 0.79 | +15.2% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.